 Commercial Syn Bags Ltd receives recognition for its in-house R&D unit
Commercial Syn Bags Ltd receives recognition for its in-house R&D unit Orchid Pharma Ltd completes purchase of assets of Allecra Therapeutics GmbH
Orchid Pharma Ltd completes purchase of assets of Allecra Therapeutics GmbH Reliance and Google Partner to Accelerate India's AI Revolution across Consumers and Enterprises
Reliance and Google Partner to Accelerate India's AI Revolution across Consumers and Enterprises Airfloa Rail crosses ₹113 Crore in new orders within a Week, Order Book nears ₹455 Crore
Airfloa Rail crosses ₹113 Crore in new orders within a Week, Order Book nears ₹455 Crore BEML Limited enters into 3 non-binding MoUs with DCIL
BEML Limited enters into 3 non-binding MoUs with DCIL 
              (Rating: BUY, Target Rs 230, Upside 39.4%)
- Greenpanel Industries delivered an exuberant performance during Q3FY21 showcasing its top notch execution qualities with a beat on all fronts. Company's MDF division witnessed phenomenal volume growth of 43.2% y/y on the back of (1) 20-25% MDF industry growth led by pick-up in usage of ready made furniture and displacement of low end plywood by MDF combined with (2) aggressive product penetration strategies as the company increased its dealer network by ~22% during 9MFY21. This along with cost optimization and operating leverage resulted into EBITDA growth of ~105% y/y for MDF division during Q3FY21.
- Based on the sublime performance during Q3FY21, we upgrade our EBITDA estimates for Greenpanel by 28.7%/16.2%/21.2% for FY21E/FY22E/FY23E respectively. Further, we factor in sales/EBITDA/PAT CAGR of 21%/32%/89% over FY21E-FY23E. Cash flow generation would be primarily deployed towards deleveraging wherein net debt should reduce from Rs 5.45 bn in FY20 to Rs 2.02 bn by FY23E.
- We upgrade our FY23E EPS from Rs 9.4 to Rs 12.4 and accordingly upgrade our TP for Greenpanel to Rs 230 - assigning DCF derived P/E multiple of 18.5x on FY23E. We maintain our BUY rating on the stock.